METHODS OF ASSOCIATING GENETIC VARIANTS WITH A CLINICAL OUTCOME IN PATIENTS SUFFERING FROM AGE-RELATED MACULAR DEGENERATION TREATED WITH ANTI-VEGF

摘要

Disclosed herein are methods and compositions for associating genetic variants with intraretinal fluid. Also disclosed herein are methods and compositions for associating genetic variants with visual acuity, anatomical outcome, or frequency of treatment.